Month: October 2021

Categories
Pharmaceutical

Demand for Americas Hospital Acquired Infection Testing Market to Attain a Valuation of US$ 2.7 Bn by 2031 end

As per Fact.MR – a market research and competitive intelligence provider, the Americas hospital acquired infection testing market was valued at US$ 595 Mn in 2020, and is expected to exhibit a CAGR of around 15% over the forecast period (2021-2031).

Infants, elderly people, and people with weak immunity systems are at a greater risk of developing hospital acquired infections (HAIs). Many common antibiotics are resistant to various organisms present in hospitals. Widespread use of antibiotics in hospitals promotes the development of resistant bacteria. Urinary tract infection (UTI), surgical site infections, pneumonia, lung infections, and bacterial infections are commonly acquired hospital infections.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=6592

As per the Centers of Disease Control and Prevention (CDC) estimates, in hospitals across the Americas alone, 1.7 million patients suffer from HAIs and 99,000 deaths occur every. This high mortality rate associated economic burden has compelled healthcare providers to device an effective strategy to lower infection rates.

The current COVID-19 pandemic crisis is expected to have a moderately positive impact on market growth. This can be attributed to growing number hospitalizations due to COVID-19 across the Americas. Prolonged hospital stays and frequent use of ventilators increase the chances of patients acquiring infections. Thus, as the number of hospitalizations is high, demand for HAI testing kits is expected to see a rise.

Key Takeaways from Market Study

  • By test, helicobacter pylori testing kits hold around 26.4% value share of the total Americas market.
  • Based on modality, point-of-care testing is leading with 69% market share.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=6592

  • By end user, diagnostic laboratories dominate the HAI testing market with a value share of 35%, while on the other hand, home care settings are expected to increase at a higher CAGR of 23%.
  • By country, the U.S. dominates the Americas hospital acquired infection testing market with a value share of 58%.

americas hospital acquired infection testing-market competition by FactMR

Segments as per Americas Hospital Acquired Infection Testing Industry Research

Modality

  • Immunoassay Testing
  • Point-of-care Testing

By Sample

  • Blood
  • Nasal Swabs
  • Urine
  • Stool

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/6592

Who is winning?

The Americas market is set to expand due to rise in incidence of hospital acquired infections. Leading industry players are set to focus on research & development as well as strategic & geographic expansion in order to strengthen their presence in the region.

Some of the leading players in the market include, but not limited to, Altona Diagnostics, bioMérieux SA, Abbott, ThermoFisher Scientific, Danaher Corporation, ELI Tech Group, Becton Dickinson, Hoffmann-La Roche Ltd, Qiagen, Pro-lab diagnostics, Liofilchem, savyonDiagnostics, and CTK Biotech.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/03/03/1994330/0/en/Sterile-Active-Pharmaceutical-Ingredients-Market-Set-for-Robust-Growth-Through-2029-Injectable-Drugs-in-Demand-Reports-a-Fact-MR-Study.html

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Hand Hygiene Monitoring System Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2277/hand-hygiene-monitoring-system-market

Dental Amalgamators Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2276/dental-amalgamators-market

Actigraphy Sensors Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2274/actigraphy-sensors-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Business

Trending Report: Deaver Retractor Market Size 2021 To 2028: Review Report With Classifications, Key Players, Revenue And Growth Assessment

The global Deaver Retractor market study presents a careful compilation of the historical, current, and future outlook of the said market as well as the factors that are responsible for such development of the market. In an effort to provide the users of this report with a comprehensive view of the global Deaver Retractor market, experts have made an inclusion of a detailed discussion on and analysis of the diverse product portfolio and competitive vendor landscape of each of the leading players spread across different territories of the world. The report study also includes both PESTEL analysis and SWOT analysis of the industry. The report also adds an analysis of market attractiveness, in which all of the market segments have been benchmarked based on general attractiveness, their rate of growth, and size of the market.

Analysts at Fact.MR have highlighted the opportunities, threats, weaknesses, and strengths of each of the players in the global Deaver Retractor market. In addition to that, the study makes an emphasis on the pattern of adoption of Deaver Retractor product / services across various industries.

Get Request for PDF Brochure of This Market Research Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2037

The Deaver Retractor market report highlights and analyses the following players:

Integra LifeSciences, Becton, Dickinson and Company, Electro Surgical Instrument Co., Medline Industries, Inc., Teleflex Incorporated, and Invuity, Inc., among others.

The Deaver Retractor market report conducts examination of the operating pattern of each of the market players – acquisitions, launch of new product launches, collaborations, and partnerships – has been investigated into detail.

The ongoing global pandemic, COVID-19, has affected the global Deaver Retractor market adversely. Manufacturing operations have been suspended across all of the leading manufacturing hubs for now and this has led to the considerable slowdown of the production processes. In addition to that, Covid-19, has taken its toll on the consumer purchasing power and demand. Uncertainties pertaining to the possible length of lockdown have made it extremely difficult to prophesize when and how the resurgence in the Deaver Retractor industry will take place. This report on the global Deaver Retractor market is expected to account Covid-19 as one of the key contributors of the market.

GLOBAL DEAVER RETRACTOR MARKET RESEARCH REPORT SEGMENTATION:

The global deaver retractor market is segmented by product type, usage, end users and region.

Based on product type, the global deaver retractor market is segmented into:

  • Deaver Retractor with handle
  • Deaver Retractor without handle

Based on usage, the global deaver retractor market is segmented into:

  • Disposable
  • Reusable

Based on end users, the global deaver retractor market is segmented into:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics

To have better understanding of regional dynamics, Global Deaver Retractor Market covers the following geographies: 

  1. North America (U.S., Canada)
  2. Latin America (Mexico, Brazil)
  3. Western Europe (Germany, Italy, France, U.K, Spain)
  4. Eastern Europe (Poland, Russia)
  5. Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  6. Japan
  7. The Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Get Request for Report Customization @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=2037

The global Deaver Retractor market report offers plentiful insights, which comprise the following:

  • Changing pattern of consumption amongst the individuals across the globe
  • The challenges, restrains, opportunities, and drivers prevailing in the Global Deaver Retractor Market
  • Emerging revenue streams for all the market players in the developing regions
  • The competitive landscape with profiles of leading market players
  • Technologies and business models with disruptive potential
  • Influence of Covid-19 in the market and how the pandemic is going to shape the contours of the market in the forthcoming years
  • Historical and future progress of the global Deaver Retractor market.
  • Regional segmentation of the Deaver Retractor market to understand the revenue, and growth lookout in these areas.
  • Precise Year-on-Year growth of the global Deaver Retractor market.

Some of the insights and aspects that make the Fact.MR report different from other business intelligence accounts are: 

  • The research has laid down the data outliers
  • Country regulations that have the potential to bring macroeconomic disruptions
  • Insights on and analysis of new business models and digital frameworks that can bear industry-wide scope
  • Trade wars in major regions and their larger economic ramifications to understand the framework of investments in the Deaver Retractor market during the assessment period
  • Myths and false assertions that have kept the demand in the Deaver Retractor market stilted

Enquiry before Buying @ https://www.factmr.com/connectus/sample?flag=EB&rep_id=2037

The report on the Deaver Retractor market presents data-driven insights and statistics-based analysis of the numerous growth aspects. Some of the more notable ones shaping the current growth trajectories are: 

  • Factors that will contract/expand output in core sectors that affect demand in the Deaver Retractor market
  • Technology trends that might boost the demand and hence revenue potential in the Deaver Retractor market
  • Recent changes in outlook on job market in the developing world which will unlock new prospects in the Deaver Retractor market
  • Analysis of new policies that may invigorate consumer spending in the key segments of the Deaver Retractor market
  • Economic clusters that have shaped the branding opportunities of top players
  • Key factors that have shaped the brand positioning leanings of new players
  • End-use industries that are likely to outperform with respect to standard narratives of the Deaver Retractor market
  • Research and development investment trends and insights into new revenue streams in key economies of the world

How can Fact.MR Make Difference?

  1. In-depth understanding of key industry trends shaping the present growth dynamics
  2. Offers value chain analysis and price trend analysis of various offering of competitors
  3. Offers data-drive decision to help companies decide strategies that need recalibration
  4. Offers insights into areas in research and development that should attract
  5. Identifies data outliers before your competitors

More Related Reports By Fact.MR On Healthcare Domain:

Brain Tissue Oxygen Monitoring Systems Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028

MRI Guided Drug Delivery Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Wireless Portable Medical Devices Market to Rise at a CAGR of 11% Through 2031

As per a new report published by Fact.MR – a market research and competitive intelligence provider, the global wireless portable medical devices market was valued at US$ 15 Bn in 2020, and is projected to top US$ 33 Bn by 2031, expanding at a CAGR of 11%.

Fact.MR anticipates significant surge in demand for wireless portable medical devices attributable to factors such as increasing adoption of technologically advanced wearables and image-guided therapy systems, coupled with the ongoing trend of accurate and real-time monitoring.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=6588

Rising geriatric population, changing lifestyle, unhealthy eating habits, and environmental factors increase the burden of diseases. Rising need for monitoring the physical activities of individuals for early diagnosis or prevention of diseases is expected to drive demand for wireless portable medical devices.

Key Takeaways from Market Study

  • Revenue from sales of wireless portable medical devices topped US$ 15 Bn in 2020, and is expected to cross US$ 33 Bn by 2031.
  • Key factors driving demand for wireless portable medical devices are rise in technologically advanced monitoring devices and growing need for accurate and real-time monitoring.
  • North America holds the largest revenue share for wireless portable medical devices of around 42%.
  • Demand for wireless portable medical devices in Asia Pacific is expected to expand at a CAGR of 11% over the next ten years.
  • Demand for wearable devices is expected to surge at a CAGR of 19% over the forecast period.
  • Application of wireless portable medical devices in gynaecology is expected to witness growth at a healthy CAGR of 14% through 2031.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=6588

wireless portable medical devices market by FactMR

Key Market Segments Covered in Wireless Portable Medical Devices Industry Research

By Product

  • Therapeutic Wireless Portable Medical Devices
  • Smart Wearable Medical Devices
  • Diagnostic Imaging Wireless Portable Medical Devices
  • Monitoring Wireless Portable Medical Devices
  • Neuromonitoring Wireless Portable Medical Devices

By Application

  • Wireless Portable Medical Devices in Cardiology
  • Wireless Portable Medical Devices in Orthopaedics
  • Wireless Portable Medical Devices in Gynaecology
  • Wireless Portable Medical Devices in Urology
  • Wireless Portable Medical Devices in Gastrointestinal
  • Wireless Portable Medical Devices in Neurology

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/6588

Winning Strategy

Most major companies are adopting key strategies such as collaborations, mergers, and acquisitions to develop novel products and innovative solutions to expand their global presence. Major players are also focusing on strategic partnerships and acquisitions to consolidate their market position.

New and upcoming companies will be benefitted by investing in R&D projects involved in product innovation. Directing investments towards technological advancements and new attractive product launches will prove to be favourable in the long run.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/03/03/1994330/0/en/Sterile-Active-Pharmaceutical-Ingredients-Market-Set-for-Robust-Growth-Through-2029-Injectable-Drugs-in-Demand-Reports-a-Fact-MR-Study.html

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Hand Hygiene Monitoring System Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2277/hand-hygiene-monitoring-system-market

Dental Amalgamators Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2276/dental-amalgamators-market

Actigraphy Sensors Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2274/actigraphy-sensors-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

How is High Prevalence of Anemia Affecting Demand for Hematology Diagnostics across the Americas

According to a new study published by Fact.MR, a market research and competitive intelligence provider, the Americas hematology diagnostics market was valued at US$ 264.3 Mn in 2020, and is predicted to expand at a CAGR of around 5% over the forecast period (2021–2031).

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=6513

Factors boosting demand for hematology diagnostics include rising incidence of blood-related diseases such as anemia and blood cancer. Hematological tests help in evaluating various conditions involving blood and its components. But these can be also performed to determine various life-threatening diseases at different stages. Blood tests can give an exact assessment of body conditions and result in early treatment.

Advancements in technology have led to the development of simple and painless blood testing systems. Moreover, development prospects of hematology diagnostics are expected to be influenced by rising investments in research & development activities of blood-related diseases. Rising healthcare expenditure and focus are expected to contribute significantly to the growth of the market over the forecast period.

Key Takeaways from Market Study   

  • Blood typing kits are expected to contribute more than 31% revenue share in the market by 2031.
  • Under modality, demand for lab-based testing is expected to increase at a CAGR of 5% through the forecast period.
  • Diagnostic laboratories dominate the market among all distribution channels, and are expect to reach a valuation of US$ 172 Mn by 2031.
  • The U.S. holds the highest share in the global market due to rising concerns about health and increasing blood related diseases, and is expected to progress at a CAGR of 4% through 2031.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=6513

americas hematology diagnostics market competition by FactMR

Categorization by Americas Hematology Diagnostics Industry Research

By Kit

  • Hematology Anemia and Iron Test Kits
  • Hematology Folic Acid Testing Kits
  • Hematology Sickle Cell Screening Kits
  • Hematology PT/INR Testing Kits
  • Hematology D-dimer Testing Kits
  • Hematology Blood Typing Kits

By Modality

  • Point of Care
  • Lab-based testing

Distribution Channel

  • Hematology Diagnostics at Hospitals
  • Hematology Diagnostics at Diagnostic Laboratories
  • Hematology Diagnostics at Cancer Research Institutes
  • Hematology Diagnostics through Retail Pharmacies
  • Hematology Diagnostics through Drug Stores

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/6513

Increasing Adoption of Point of Care Services Likely to Propel Market Growth

Point of care tests are gaining popularity because of many factors such as convenience, early diagnosis, and cost effectiveness.

Due to early detection of diseases and the ongoing COVID-19 pandemic, people are opting for point of care diagnosis. It will also reduce the chances of spread of infectious diseases.

Competition Outlook

While the hematology diagnostics market is a fairly fragmented in the Americas region, Grifols SA, Abbott Laboratories, F. Hoffmann La Roche Ltd., and bioMerieux hold nearly 50% market share. Tier-2 and tier-3 players hold the remaining half of the global market share.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/03/17/2001977/0/en/Demand-for-Hospital-Supplies-to-Heighten-with-Severing-Concerns-over-Hospital-Infections-Global-Market-Value-to-Surpass-US-21-Bn-by-2029-Fact-MR.html

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Hand Hygiene Monitoring System Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2277/hand-hygiene-monitoring-system-market

Dental Amalgamators Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2276/dental-amalgamators-market

Actigraphy Sensors Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2274/actigraphy-sensors-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Adoption of Drug Eluting Balloon Catheter to Surge Owing to the Increased In Demand for the Treatment of Coronary Artery Disease

Fact MR analysis of Drug Eluting Balloon Catheter market provides compelling insights into the factors propelling sales prospects in key segments such as Indicatione (Coronary Artery Disease,Peripheral Vascular Diseas), End User ( Hospitals,Ambulatory Surgical Centers,Cardiac Catheterization Laboratories), and Raw Material ( Polyurethan,Nylon). It provides an executive-level blueprint of key market players’ strategies and analyses their impact on overall growth projections.

Drug eluting balloon catheter is witnessing robust adoption owing to its overwhelming results in cardiovascular and peripheral artery procedures. Moreover, drug eluting balloon catheter is also turning out to be useful for patients who are unable to undergo percutaneous coronary intervention (PCI) procedures.

Encouraged by this situation, various drug eluting balloon catheter manufacturers across the globe are now increasing their production capacity. The aforementioned factors are reflecting favorably on the global sales of the drug eluting balloon catheter.

Also, companies are aiming to manufacture cost-effective catheters in order to increase market penetration. The growing prevalence of cardiovascular diseases and soaring incidences of cardiology intervention procedures is facilitating the growth of the global drug-eluting balloon catheter market.

For More Insights Into The Market, Request a Sample of this Report

https://www.factmr.com/connectus/sample?flag=S&rep_id=146

Improvement in Predictive Analytics Across Healthcare is Driving the Growth Of Drug Eluting Balloon Catheter Market

Increasing awareness regarding the individual’s health coupled with the ongoing advancement in healthcare infrastructures such as improvement in data science and predictive analytics are creating lucrative growth opportunities for the Drug Eluting Balloon Catheter market.

Fact.MR projects that the global market for drug eluting balloon catheter will surge at a robust CAGR between 2018 and 2022. In addition, factors such as enhanced reimbursement policies, rising geriatric population, and growing healthcare expenditure are anticipated to positively impact the market’s growth.

The arrival of new-generation drug eluting balloon catheters as well as heavier investments in R&D pipelines in order to increase its utility is also anticipated to create lucrative growth opportunities for manufacturers and stakeholders in the global market for drug eluting balloon catheters.

Market Taxonomy

Indicatione
  • Coronary Artery Disease
  • Peripheral Vascular Diseas
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
Raw Material
  • Polyurethane
  • Nylon
  • Others

Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=RM&rep_id=146

Key Insights From the Report Include: 

  • Among regions, Europe will retain its dominant position in the market over the forecast period. Between 2017 and 2022, the drug eluting balloon catheter market in Europe will reflect a CAGR of 20.5%. Meanwhile, the Asia-Pacific excluding Japan (APEJ) market will also witness robust growth over the next couple of years.
  • By indication, drug eluting balloon catheter will be used mostly for treating coronary artery disease. Currently, the coronary artery disease indication segment will command for more than two-third revenue share of the global market.
  • Hospitals will remain the largest end-user of drug eluting balloon catheter in 2017 and 2022. Sales of drug eluting balloon catheter currently command for close to 73% market share in terms of revenue. Hospitals are one of the most preferred medical settings for undertaking coronary artery and restenosis procedures.
  • By raw material, demand nylon-based drug eluting balloon catheter will continue to gain traction over the assessment period. Currently, sales of nylon-based drug eluting balloon catheter account for close to 54.1% revenue share of the global market. Towards the end of 2022, more than US$ 244 Mn worth of nylon drug eluting balloon catheters are expected to be sold worldwide.

Full Access of this Report Is Available At

https://www.factmr.com/checkout/146

Competition Tracking

  • Cardionovum GmbH
  • Cook Medical INC
  • Cordis Corporation
  • Abbott Laboratories
  • Meril Life Sciences Pvt Ltd
  • Jotech GmbH
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • Boston Scientific Corporation
  • Tokai Medical Products Inc.
  • BIOTRONIK SE & Co. KG
  • B. Braun Melsungen AG
  • Medtronic Plc.

For More Insights

https://www.biospace.com/article/emergence-of-pharma-tech-and-new-product-launches-is-driving-growth-of-global-analytical-gel-permeation-chromatography-market-notes-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Shoulder Implants to Record a CAGR of 6.5% over the Forecast Period by 2027

250 Pages Orthopedic Implants Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

Fact MR analysis of the orthopedic implants market provides compelling insights into the factors propelling sales prospects in key segments such as Product Type, Fixation Type, and End User. It provides an executive-level blueprint of key market players’ strategies and analyses their impact on overall growth projections.

The orthopedic implants market continues to be a promising avenue in the global medical technology space. Emergence of advanced technologies coupled with rise in orthopedic disorders are major growth determinants for the orthopedic implants market. A recent report by Fact.MR envisions the demand for orthopedic implants to record an august 6.5% CAGR over the forecast period 2018 to 2027.

Although surgeries of orthopedic implants incorporating robotics offer reproducible precision and are less invasive, expensiveness of the technology coupled with the requirement for robust, evidence-based studies continues to impede its adoption in orthopedic surgeries.

For More Insights Into The Market, Request a Sample of this Report

https://www.factmr.com/connectus/sample?flag=S&rep_id=990

orthopedic implants market

Global Orthopedic Implants Market: Segmentation

By Product Type

Hip Reconstruction
Knee Reconstruction
Shoulder Implants

By Fixation Type

Cement
Cementless
Hybrid

By End User

Hospitals
Orthopedic Clinics
Ambulatory Surgical Centers

Digital Transformation in Healthcare Presenting Opportunities for Orthopedic Implants Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Orthopedic Implants market.

Following Questions Answers Covered in the Report are:

  • How will the global Orthopedic Implants Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Orthopedic Implants Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Orthopedic Implants Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=990

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights –http://www.globenewswire.com/en/news-release/2018/07/06/1534093/0/en/Pet-Wearables-Market-to-Surpass-a-Valuation-of-US-3-463-Mn-Over-2022-Finds-Fact-MR.html

Revenues from sales of orthopedic implants for hip reconstructed exceeded US$ 16,800 Mn in 2017.

North America’s preeminent in the orthopedic implants market will continue to prevail, states Fact.MR study. According to American Joint Replacement Registry (AJRR), over 7 million America have been associated with knee and hip reconstruction surgeries collectively. Over half revenue share of the market will be accounted by orthopedic implants sales in North America by 2027-end.

The U.S. Food and Drug Administration (FDA) has approved a slew of robotic surgery systems for orthopedic implants, with the da Vinci Surgical System being the first one. More companies have been investing in the technology for providing a better navigation during the procedure, and obtain 3D scans to aid designing of customized joints.

Acquisitions and mergers continue to be key strategic expansion methods adopted by companies operating in the orthopedic implants market. Acquisition of Mako Surgical Corp. by Stryker – for total hip and knee construction robotic products for orthopedic implants, and Blue Belt Holdings by Smith & Nephew for robot-assisted orthopedic implant surgery product for partial knee replacements are prime instances of such strategic expansions.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=990

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Increasing Demand for Cancer Profiling Tests to Substantially Surge the Revenues Through 2028

250 Pages Cancer Profiling Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

Fact MR analysis of cancer profiling market provides compelling insights into the factors propelling sales prospects in key segments such as Product Type, Indication, and Test Type ,End User. It provides an executive-level blueprint of key market players’ strategies and analyses their impact on overall growth projections.

According to the study, cancer profiling market revenues continue to remain consolidated in North America. Of the estimated new cases, breast cancer accounts for over 15% and colorectal cancer for about 8% new cases. As breast and colorectal cancers are few of the leading causes of death in North America, collectively they register nearly 70% of total regional cancer profiling revenues.

Focus on improving overall patient care will remain a chief growth driver. Besides this, cancer profiling market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To offer an in-depth overview, the report provides sales projections for over 20 countries. It also identifies segments exhibiting maximum growth potential on the basis of Product Type, Indication, and Test Type.

Request a Report Sample to Gain Comprehensive Market Insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=358

Digital Transformation in Healthcare Presenting Opportunities for Cancer Profiling Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the cancer profiling market.

cancer profiling tests price analysis us unit by region

Key Cancer Profiling Survey Highlights and Projections

Driven by higher investment in innovation, the U.S. will emerge as the dominant Cancer Profiling market in North America, accounting for 4.7% of overall sales registered in 2028.

With the presence of some of the world’s leading healthcare companies, coupled with high spending on hospital services, the U.K. and Germany will emerge as highly lucrative pockets in Europe.

Investment towards healthcare sector expansion and focus on medical tourism will make China, Japan, and South Korea key markets within East Asia.

Speak to Research Analyst

https://www.factmr.com/connectus/sample?flag=AE&rep_id=358

Report Benefits & Key Questions Answered

Cancer Profiling Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.

Cancer Profiling Historical volume analysis: The report provides a comparison of Cancer Profiling’s historical sales and projected sales performance for 2021-2031.

Cancer Profiling Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Cancer Profiling market. It carefully gauges the impact of changing healthcare needs of key demographics globally

Cancer Profiling Consumption by demographics: The report investigates consumer behavior affecting Cancer Profiling demand outlook for the assessment period. Effect of their keenness for digital trends on Cancer Profiling market is carefully analyzed

Post COVID consumer spending on Cancer Profiling: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Cancer Profiling market growth.

Competitive Landscape Analysis

The study offers insights into key trends affecting healthcare industry, subsequently influencing demand supply forces in the Cancer Profiling market.

  • F. Hoffmann La Roche Ltd
  • Illumina Inc
  • QIAGEN
  • Thermo Fisher Scientific Inc
  • Abbott
  • Nanostring Technologies Inc
  • Siemens AG
  • HTG Molecular Diagnostics, Inc
  • Perkin Elmer Inc
  • Agilent Technologies Inc
  • Negenomics Laboratory Inc

To offer an in-depth analysis of prevailing competition, the report offers a detailed market share analysis. In this chapter market players are segregated in terms of Tier 1, Tier 2, and Tier 3 companies. Strategies adopted by players across these categories and impact of the same on the overall market are studied at length.

Full Access of this Report Is Available at https://www.factmr.com/checkout/358

Cancer Profiling Demand Analysis by Category

Product Type

Immunohistochemistry (IHC) Analyzers
Fluorescence In situ Hybridization (FISH) Instruments
PCR instruments
DNA Sequencer
Fragment Analyzer
Consumables
Reagents & Kits
Other Ancillary (probes, holders etc.)

By Indication

Breast Cancer
Colorectal Cancer
Ovarian Cancer
Melanoma
Kidney Cancer
Lung Cancer (including NSCLC)
Rare Cancers

By End User

Hospitals
Diagnostic Centres
Cancer Research Institutes

Region

North America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

For More Insights https://www.biospace.com/article/linear-motion-systems-sales-surged-by-increment-in-industrial-production-across-the-globe-says-fact-mr/

Cancer Profiling Market – Additional Questions Answered

In addition to the aforementioned insights, the cancer profiling market report delivers intelligent insights based on a thorough assessment of all the market facets. These insights can answer to some of the bemusing questions of the business professional interested in the cancer profiling market.

  • Which product type in the cancer profiling market will register significant demand by the end of the assessment period?
  • Which region presents considerable utilization of cancer profiling tools?
  • Among different test types, which test type will be highly sought after in the cancer profiling market during the forecast period?
  • Which end-user will register leading utilization of cancer profiling tests during the forecast period?

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for ccfDNA Isolation Kits Is Poised to See a Healthy Growth Outlook at 6% CAGR During 2019 – 2029

Surpassing revenues worth US$ 215 Mn in 2019, sales of blood collection tubes for liquid biopsy are poised to see a healthy growth outlook at 6% CAGR during 2019 – 2029. Despite being an essential diagnostic product in the practice of laboratory biopsy testing, the blood collection tubes for liquid biopsy market is still young, and the application scope remains majorly limited to research industry.

High product availability is limited to developed regions such as North America, Europe, and Oceania. However, increased application of blood collection tubes for liquid biopsy in genetic diagnostics and other common diagnostic procedures is likely to bolster demand for blood collection tubes for liquid biopsy in following years.

The healthcare industry is consistently witnessing an increase in the number of biopsy procedures every year, globally, due to the increasing prevalence of cancer. Growing awareness and rise in cancer screening procedures has led to the growth of the blood collection tubes for liquid biopsy market which in turn has increased the rate of early diagnosis of cancer.

For More Insights Into The Market, Request a Sample of this Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=4495

Key Segments of the Blood Collection Tubes for Liquid Biopsy Market

Fact.MR’s study on the blood collection tubes for liquid biopsy market offers information divided into four important segments-product, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Products
  • Plastic
  • Glass
Application
  • IVD
  • Research Use
End User
  • Healthcare Centers
  • R&D Centers
  • Diagnostic Centers
Region
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Access Research Methodology Prepared By Experts –
https://www.factmr.com/connectus/sample?flag=AE&rep_id=4495

Key Takeaways – Blood Collection Tubes for Liquid Biopsy

  • Healthcare centers would show remarkable growth in adoption of blood collection tubes for liquid biopsy owing to the rise in number of research activities.
  • Increasing prevalence of cancers will remain one of the major factors responsible for the growth of the blood collection tubes for liquid biopsy market.
  • Blood collection tubes for liquid biopsy market is a fragmented landscape.
  • Growing demand for single needle penetration for multiple tests is identified as the key growth engine, pushing adoption of blood collection tubes for liquid biopsy.

Key Players

  • Roche
  • Streck
  • Preanalytix
  • Norgen Biotek
  • Biocept

blood collection tubes for liquid biopsy market 02

Plastic Tubes Remain Highly Sought-after

On back of higher safety standards, plastic blood collection tubes for liquid biopsy will continue to gather preference over their glass counterparts. The former remains preferred for their greater reliability during routine clinical chemistry analysis, tumor screening, biopsy tests and chemotherapeutic drug monitoring. The shatter-resistant plastic further reduces the risk of exposure to pathogens and contamination.

Attractiveness of Asian Markets Intact

Growth opportunities for the blood collection tubes for liquid biopsy market players is picking up the pace in the East and South Asian regions. Increasing availability of economically affordable blood collection tubes would also be a significant booster to market growth. A large number of local manufacturers, particularly in China, Japan, and India, are increasing the scope for manufacturers and boosting the blood collection tubes for liquid biopsy market growth.

Full Access of this Report Is Available at
https://www.factmr.com/checkout/4495

Know More About Blood Collection Tubes for Liquid Biopsy Market

Fact.MR’s business intelligence also underlines groundbreaking insights into the competitive scenario of the blood collection tubes for liquid biopsy market, along with highlights of manufacturers’ differential strategies. The blood collection tubes for liquid biopsy market is majorly covered by the players offering conventional blood collection tubes for liquid biopsy. The key players’ operating in the blood collection tubes for liquid biopsy market will continue to focus on delivering of their products through direct sales and distribution channels.

Key Questions Answered in Fact.MR’s Blood Collection Tubes for Liquid Biopsy Market Report

  • Which regions will continue to remain the most profitable for blood collection tubes for liquid biopsy market players?
  • Which factors will induce a change in the demand for blood collection tubes for liquid biopsy during the assessment period?
  • How will the changing trends impact the blood collection tubes for liquid biopsy market?
  • How will the market players capture the untapped market opportunities in the blood collection tubes for liquid biopsy market?
  • How local players’ products will impact the adoption of blood collection tubes for liquid biopsy?

For More Insights 
https://www.biospace.com/article/bell-s-palsy-treatment-demand-propelled-by-growing-prevalence-of-bell-s-palsy-says-fact-mr

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Addition Of New Therapies Is Contributing To Sales Growth Of Diverticular Disease Therapeutics Market

Fact.MR,  has used different approaches to focus their attention on the demand and sales of the Diverticulitis Drugs Market. This study provides a comprehensive analysis of key trends, key growth paths for the 2018-2028 estimated year.

Diverticula Disease Drugs Market Drivers and Constraints, Threats and Opportunities, Regional Segmentation and Opportunity Assessment, and End-Use/Application Prospect Review are covered in the Diverticula Disease Drugs Market research report.

Market Overview

Diverticulosis disease usually occurs in people over the age of 40 and its prevalence is increasing over time. About 10% of people over 40 and 50% of people over 60 will have diverticulum disease at some point.

The disease was first identified in the 1930s to share many features of inflammatory bowel disease. Diverticular disease is characterized by the formation of small protrusions or stalks called diverticulum in the walls of the colon. The sigmoid colon is more susceptible to diverticulum formation.

To get In-depth Insights Request For Brochure Here –https://www.factmr.com/connectus/sample?flag=B&rep_id=930

The Diverticulitis Treatments market study estimates the size of the Diverticulitis Treatments market and overall sales and shares of key regional segments. We leverage space-age industrial and digitalization tools to provide our clients with avant-garde actionable diverticulum disease therapeutics market demand and insights.

The latest research report analyzes the diverticulopathy therapeutics market demand by different segments. It provides business leaders with insight into diverticulum disease treatments and ways to increase market share.

Diverticular Disease Therapeutics’ market insights will improve the revenue impact of businesses in a variety of industries by:

Providing a tailored framework to understand the attractiveness index of various products/solutions/technology in the diverticulitis treatment market, guiding stakeholders to identify key problem areas related to their integration strategies in the global diverticuloma treatment market and providing solutions for
companies to expand their footsteps

The regulatory impact assessment of the dynamics of change in the area eager to provide an understanding of the disruptive technology trends to allow a smooth transition to the company.

Supporting leading companies to realign their strategies ahead of their competitors and peers

providing insights into promising synergies for top players aiming to maintain their leadership positions in market and supply-side analysis of the Diverticula Disease Drugs market.

Up-to-date industry analysis and survey of Diverticula Disease Therapeutics provides sales forecasts in more than 20 countries across key categories. Insights and prospects for Diverticula Disease Drugs market drivers, trends, and influencing factors are also included in the study.

Diverticular Disease Therapeutics Market: Segmentation

Tentatively, the global diverticular disease therapeutics market can be segmented on the basis of treatment, indication, distribution channel, and geography.

Based on treatment, the global diverticular disease therapeutics market is segmented as:

  • Antibiotics Treatment
  • Symptomatic Treatment

Based on indications, the global diverticular disease therapeutics market is segmented as:

  • Symptomatic Uncomplicated Diverticular Disease
  • Recurrent Symptomatic Diverticular Disease
  • Complicated Diverticular Disease.

Based on distribution channel, the global diverticular disease therapeutics market is segmented as:

  • Hospital Pharmacy
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacy
  • Others

Diverticula Disease Drugs Market: Overview

The global market for the treatment of diverticulitis is expected to witness moderate growth during the forecast period. Most of the antibiotics are introduced into the generic market, resulting in fierce competition between regional and regional players.

Of the two treatment types, the antibiotic therapy segment is expected to drive the global diverticulosis treatment drugs market during the forecast period. The retail pharmacy distribution channel is the most accessible channel and is expected to contribute to its high share in the global diverticulopathy treatment market as most patients recommend outpatient care.

Enquiry Before Buying –https://www.factmr.com/connectus/sample?flag=EB&rep_id=930

Answers to Key Questions in Fact.MR’s Diverticula Disease Therapeutics Market Report Research

Diverticula Disease Drugs Company and Brand Share Analysis: The company and brand share analysis of the Diverticulitis Drugs market shows how much market share Tier 1, Tier 2, and Tier 3 players are holding.

Diverticulitis Treatments Market Historical Volume Analysis: The industry analysis provides data and insights on historical volume sales of Diverticulitis Treatments.

Diverticulitis Treatments Category and Segment Level Analysis: Fact.MR’s Diverticulitis Treatments market sales outlook is lucrative and provides category and segment level analysis for initial product types. Market participants can use this information to identify sales potential and set sales targets at regional, national and regional levels.

Diverticulitis Drugs Market Consumption by Demographics: Market intelligence studies provide consumption by demographic analysis, allowing market participants to design products and marketing strategies based on high-value consumers.

Post-Corona Consumer Spending on Diverticula Disease Drugs Market: The report includes post-coronavirus consumer spending analysis. This information helps business leaders understand changes in purchasing power and behavior.

Manufacturing Trend Analysis: Critical information on how market players are adjusting their manufacturing strategies in response to evolving consumer sentiment.

Diverticula Disease Drugs Market Mergers and Acquisitions Activity: MR’s analysis also includes analysis of mergers and acquisitions activity. Diverticulitis Drugs market manufacturers and stakeholders will not only be aware of the recent M&As, but will also understand the competitive landscape and their impact on market share.

Diverticula Disease Drugs Market Demand by Country: The report forecasts the diverticulitis Drugs demand by country, providing business leaders with insight into a fast growing, stable and mature market.

The report also offers an in-depth analysis of the key trends in the market and how the projected growth factors will shape the market dynamics in the coming years.

Additionally, it provides meaningful and actionable insights into competitive analysis that will be beneficial to the future demand of the Diverticula Disease Drugs market.

Key insights from the Diverticulitis Drugs Market research report:

Basic macro- and micro-economic factors influencing the diverticulum disease therapeutics market sales.
Basic overview of Diverticula Disease Therapeutics including market definitions, classifications and applications.
We scrutinize each market participant based on M&A, R&D projects and product launches.
Analysis of the introduction trend and supply side of diverticulum disease treatment across various industries.
Important regions and countries that provide lucrative opportunities for market stakeholders.
The demand for Diverticulitis Drugs Market research includes the current market scenario of the global platform and the Diverticulitis Drugs Market developments and sales.

Request Customized Report as Per Your Requirements –https://www.factmr.com/connectus/sample?flag=RC&rep_id=930

Diverticular Disease Therapeutics Market: Key Players

The global market for diverticular disease therapeutics is highly fragmented. Examples of some of the key players operating in the global diverticular disease therapeutics market are Shire Plc., Cook Group Incorporated, Allergen Plc., Salix Pharmaceuticals Inc. novoGI, Inc., SCLNOW BIOTECHNOLOGY CO.,LTD., Sandoz (Novartis AG), Glaxosmithkline Inc., Pfizer Inc., Gilead Sciences, Inc., and Fresenius Kabi AG, among others.

The competitive landscape analysis of the Diverticulitis Drugs Market includes detailed profiles of Tier 1, Tier 2 and Tier 3 players. Each market share of the Diverticulitis Drugs manufacturers is provided to help business leaders understand the market scenario.

Diverticular Disease Therapeutics Market: Regional Outlook

Geographically, the global diverticular disease therapeutics market is segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA).

North America is expected to be dominant market in the global diverticular disease therapeutics market owing to high prevalence of the disease. The diverticular disease therapeutics market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to expansion of product offerings by the key players. Europe is expected to have second large share in the global diverticular disease therapeutics market throughout the forecast period.

More Related Reports By Fact.MR On Healthcare Domain :

Subcutaneous Injection Ports Market Forecast, Trend Analysis & Competition Tracking – Global Review 2018 to 2026

Drug-Loaded Oral Thin Films Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2026

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Behavioural Health Treatment Software Is Estimated CAGR of 2.4% Over the Assessment Period

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data. Creating outcome-oriented financial models to maximize reimbursements in value-based healthcare will be a strategic shift from the traditional fees-for-services model. This implies that pharmaceutical companies will need to devise appropriate measures to optimize costs and improve the quality of patient care.

Burden of mental illness on Europe’s economy is among the largest in the world, inadvertently making it the most lucrative region for players in the behavioural health treatment market, with the region slated to account for a staggering 47% of the global market by 2027. Total cost associated with mental health treatment amounted to around US$ 668 Bn in 2018 across the EU, translating to 4% of the GDP of Europe. Taking cue from this opportunity, key players are striving to expand their treatment facilities to offer easy accessibility to patients.

For More Insights Into The Market, Request a Sample of this Report –

https://www.factmr.com/connectus/sample?flag=S&rep_id=4370

However, uneven distribution of therapy facilities and rehabilitation centres in rural regions across the globe is projected to result in sluggish growth of the behavioural health treatment market, with an estimated CAGR of 2.4% during the forecast period (2020-2027).

A senior analyst at Fact.MR opines,“Advent of on-demand service model will remain crucial for the behavioural health treatment market, especially in developing regions, on account of high social stigma related to opting for mental health therapy. Additionally, value-based subscription models offered by on-demand counselling would be easy on the pockets of patients, which is projected to drive a massive shift from hospital and outpatient-based care to home-based care.”

Key Takeaways of Behavioural Health Treatment Market Study

  • According to WHO, 800,000 suicides are recorded every year, on the back of depression and anxiety disorders. Symptoms of depression are found to be high among millennial cohort as compared to other age groups, influenced by reckless use of social media and stressful lifestyles. Revenue generation through patient base suffering from depression is projected to grow by 3.2% in 2027 over 2026.
  • Individuals will continue to show a high interest in outpatient counselling services, as these programs offer freedom of movement over inpatient hospital treatment services. Given the high relevance of this influence, outpatient counselling services are projected to witness a marginal rise, at a CAGR of around 2.7% during the forecast period.
  • Social stigma associated with mental health discourages individuals from seeking proper treatment and counselling, which could hinder behavioural health treatment market growth during the forecast period.
  • Asia Pacific is projected to record the highest growth rate of nearly 2.8% during 2020-2027, which is attributable to increase in service centres and debunking of mental health taboos through awareness campaigns by various government and non-governmental organizations.

Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=S&rep_id=4370

Behavioural Health Treatment Market – Assessment of Key Segments

Disorder
  • Depression
  • Anxiety
  • Schizophrenia
  • Bipolar Disorder
  • Alcohol Use Disorders
  • Substance Use Disorders
  • Eating Disorders
  • Post-traumatic Stress Disorders
  • Others
Service
  • Inpatient Hospital Treatment Services
  • Outpatient Counselling
  • Emergency Mental Health Services
  • Home-based Treatment Services
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Full Access of this Report Is Available At

https://www.factmr.com/checkout/4370

market share estimation of key regions in behavioural health treatment market

Key Players Listed in this Comprehensive Report on the Behavioural Health Treatment Market Include

Although the behavioural health treatment market boasts of a number of organized players, numerous individual practitioners operating at regional and local levels generate a significant chunk of revenue. Lack of stringent regulations for practicing behavioural health services reduces the entry barrier in the market, and further adds a layer of fragmentation to the behavioural health treatment market.

Key focus of players to strengthen their foothold in the behavioural health treatment market remains on the expansion of inpatient care facilities. For instance, in January 2019, Acadia Healthcare announced the acquisition of Whittier Pavilion, which is an inpatient psychiatric facility with 71 beds. In May 2019, MercyOne Central Iowa and Universal Health Services, Inc. established a new facility at Iowa, with 100 beds, to offer high quality services for behavioural health.

  • Promises Behavioural Health
  • Pyramid Healthcare
  • Acadia Healthcare
  • Ascension Seton
  • CareTech Holdings PLC
  • STRATEGIC BEHAVIOURAL HEALTH
  • The MENTOR Network
  • North Range Behavioural Health
  • Universal Health Services Inc.
  • Behavioural Health Network Inc.

For More Insights https://www.biospace.com/article/bone-marrow-processing-systems-growth-driven-by-progressions-in-bone-marrow-needles-and-harvest-technology-says-fact-mr/

Find More Valuable Insights on Behavioural Health Treatment Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global behavioural health treatment market, presenting historical demand data (2017-2019), and forecast statistics for the period 2020-2027. The study divulges compelling insights on the behavioural health treatment market on the basis of disorder (depression, anxiety, schizophrenia, bipolar disorder, alcohol use disorders, substance use disorders, eating disorders, post-traumatic stress disorders (PSTD), and others), service (inpatient hospital treatment services, outpatient counselling, emergency mental health services, home-based treatment services, and others), across five major regions.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com